We are live on ! Find out more
KAM

Kazazian Asset Management Portfolio holdings

AUM $91.5M
1-Year Est. Return 35.36%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+35.36%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.4M
AUM Growth
-$2.44M
Cap. Flow
+$4.55M
Cap. Flow %
4.76%
Top 10 Hldgs %
49.5%
Holding
93
New
11
Increased
17
Reduced
38
Closed
8

Top Buys

Rank Stock Value
1
XOP icon
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
+$2.15M
2
BIIB icon
Biogen
BIIB
+$1.77M
3
INTC icon
Intel
INTC
+$1.21M
4
CLVS
Clovis Oncology, Inc.
CLVS
+$993K
5
ORCL icon
Oracle
ORCL
+$903K

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$976K
2
PPLI
People Inc
PPLI
+$900K
3
MU icon
Micron Technology
MU
+$884K
4
JUNO
Juno Therapeutics, Inc.
JUNO
+$836K
5
GM icon
General Motors
GM
+$688K

Sector Composition

Rank Sector Weight
1 Healthcare 28.25%
2 Consumer Discretionary 9.29%
3 Financials 8.39%
4 Technology 6.79%
5 Communication Services 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NBL
51
DELISTED
Noble Energy, Inc.
NBL
$411K 0.43%
13,572
-1,368
-9% -$41.2K
CLLS
52
Cellectis
CLLS
$285M
$410K 0.43%
+13,008
New +$411K
PXD
53
DELISTED
Pioneer Natural Resource Co.
PXD
$389K 0.41%
2,262
-228
-9% -$40.2K
LCI
54
DELISTED
Lannett Company, Inc.
LCI
$388K 0.41%
6,048
+767
+15% +$59.1K
PE
55
DELISTED
PARSLEY ENERGY INC
PE
$363K 0.38%
12,535
-1,264
-9% -$33.7K
CTRA
56
DELISTED
Coterra Energy
CTRA
$359K 0.38%
14,986
-1,510
-9% -$38.8K
AAMC
57
DELISTED
Altisource Asset Management Corp
AAMC
$349K 0.37%
9,056
-804
-8% -$31.7K
RARE icon
58
Ultragenyx Pharmaceutical
RARE
$2.55B
$332K 0.35%
6,508
– –
PTEN icon
59
Patterson-UTI
PTEN
$3.76B
$330K 0.35%
18,850
-1,900
-9% -$39.7K
ICPT
60
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$320K 0.34%
5,204
– –
ARRY
61
DELISTED
Array Biopharma Inc
ARRY
$317K 0.33%
19,429
-9,938
-34% -$159K
GM.WS.B
62
DELISTED
General Motors Company
GM.WS.B
$314K 0.33%
16,814
– –
APA icon
63
APA Corp
APA
$13.2B
$308K 0.32%
8,011
-808
-9% -$32.5K
ECYT
64
DELISTED
Endocyte, Inc. Common Stock
ECYT
$296K 0.31%
+32,523
New +$179K
GDXJ icon
65
VanEck Junior Gold Miners ETF
GDXJ
$8.46B
$286K 0.3%
8,903
-1,961
-18% -$64.4K
BMRN icon
66
BioMarin Pharmaceuticals
BMRN
$12.4B
$264K 0.28%
3,254
– –
NBIS
67
Nebius Group N.V.
NBIS
$47.7B
$264K 0.28%
6,693
– –
SRRA
68
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$256K 0.27%
+3,095
New +$351K
BTU icon
69
Peabody Energy
BTU
$2.9B
$254K 0.27%
6,960
-718
-9% -$28.6K
DHC
70
Diversified Healthcare Trust
DHC
$2.14B
$233K 0.24%
14,877
– –
CORI
71
DELISTED
Corium International, Inc.
CORI
$224K 0.23%
+19,518
New +$235K
CCS icon
72
Century Communities
CCS
$2.03B
$206K 0.22%
6,890
-595
-8% -$18.9K
NTLA icon
73
Intellia Therapeutics
NTLA
$1.67B
$206K 0.22%
+9,757
New +$240K
WFT
74
DELISTED
Weatherford International plc
WFT
$194K 0.2%
84,825
-8,550
-9% -$27.3K
VWTR
75
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$147K 0.15%
12,858
-604
-4% -$7.42K
1 2
3
4

Similar funds

MRP
Measured Risk Portfolios San Diego, California $91.4M AUM 0.88% 1-Year Est. Return
ITG
Index Technologies Group New York $91.8M AUM
MA
Marquette Associates Chicago, Illinois $91.9M AUM 13.47% 1-Year Est. Return
AW
Aspirean Wealth Mill Valley, California $92.1M AUM
SPCM
Spruce Point Capital Management New York $90.9M AUM
ML
MLP3 LLC Linwood, New Jersey $90.7M AUM
ICM
Incision Capital Management San Francisco, California $90.6M AUM
ACMC
Anchor Capital Management Company Raleigh, North Carolina $92.7M AUM 19.36% 1-Year Est. Return

Kazazian Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Kazazian Asset Management held 93 positions worth $95.4M, down 2.5% from $97.9M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Kazazian Asset Management deployed $4.55M of net new capital in Q1 2018, opening 11 new positions and adding to 17 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 15,000 shares worth $2.11M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was General Motors, an estimated $688K trimmed.

  • Kazazian Asset Management's largest Q1 2018 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 15,000 shares worth $2.11M.
  • Kazazian Asset Management added most to Biogen in Q1 2018, an estimated $1.77M increase.
  • Kazazian Asset Management's biggest Q1 2018 reduction was General Motors, cutting an estimated $688K.
  • Kazazian Asset Management fully exited Vertex Pharmaceuticals in Q1 2018, selling an estimated $976K.
  • Kazazian Asset Management's ten largest holdings make up 50% of its $95.4M portfolio in Q1 2018.
  • Kazazian Asset Management opened 11 new positions and closed 8 in Q1 2018.
  • Kazazian Asset Management's portfolio value fell 2.5% quarter-over-quarter to $95.4M.

Based on Kazazian Asset Management's 13F filing for Q1 2018, filed 15 May 2018.